Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/12/19 11:17:15」(JST)

wiki en

Antifolates are drugs that impair the function of folic acids.^[1] Many are used in cancer chemotherapy, some are used as antibiotics or antiprotozoal agents.

A well-known example is methotrexate. This is a folic acid analogue, and owing to structural similarity with it binds and inhibits the enzyme dihydrofolate reductase (DHFR), and thus prevents the formation of tetrahydrofolate. Because tetrahydrofolate is essential for purine and pyrimidine synthesis, its deficiency can lead to inhibited production of DNA, RNA, and proteins (as tetrahydrofolate is also involved in the synthesis of amino acids serine and methionine).

Since antifolates interfere with metabolism (of nucleotides), they are categorized as antimetabolites.

Other antifolates include trimethoprim, pyrimethamine, and pemetrexed.

Many are primarily DHFR inhibitors, but raltitrexed is an inhibitor of thymidylate synthase, and pemetrexed inhibits both and a third enzyme.

Indications[edit]

Low-dose methotrexate is used to treat a wide variety of diseases such as rheumatoid arthritis, lupus, scleroderma, psoriasis, asthma, sarcoidosis, primary biliary cirrhosis, polymyositis, choriocarcinomas, spinal fluid leukemia, breast cancer, head and neck cancer, osteogenic sarcoma and inflammatory bowel disease.^[2]

Mechanism[edit]

Many are primarily DHFR inhibitors, but raltitrexed is an inhibitor of thymidylate synthase, and pemetrexed inhibits both and a third enzyme.

Antifolates act specifically during DNA and RNA synthesis, and thus are cytotoxic during the S-phase of the cell cycle. Thus, they have a greater toxic effect on rapidly dividing cells (such as malignant and myeloid cells, and GI & oral mucosa), which replicate their DNA more frequently, and thus inhibits the growth and proliferation of these non-cancerous cells as well as causing the side-effects listed.

Limitations[edit]

Side-effects[edit]

The antifolate action specifically targets the fast-dividing cells, and tend to have adverse effects on the bone marrow, skin, and hair. As folate is vital in the first trimester of pregnancy for healthy fetal development, the use of antifolates is strongly contraindicated in pregnancy and carries significant teratogenic risk.

Low doses of methotrexate can deplete folate stores and cause side-effects that are similar to folate deficiency. Both high-folate diets and supplemental folic acid may help reduce the toxic side-effects of low-dose methotrexate without decreasing its effectiveness.^[3]^[4] Anyone taking low-dose methotrexate for the health problems listed above should consult with a physician about the need for a folic acid supplement.

Resistance[edit]

While the role in folate as a cancer treatment is well established, its long-term effectiveness is diminished by cellular response. In response to decreased tetrahydrofolate (THF), the cell begins to transcribe more DHF reductase, the enzyme that reduces DHF to THF. Because methotrexate is a competitive inhibitor of DHF reductase, increased concentrations of DHF reductase can overcome the drugs inhibition.

Many new drugs are under development to reduce antifolate drug resistance.^[5]^[6]

Images[edit]

Folic acid
Methotrexate
Pemetrexed
Raltitrexed
Pralatrexate

References[edit]

^ "NCI: antifolate".
^ Morgan SL, Baggott JE (1995). "Folate antagonists in nonneoplastic disease: proposed mechanisms of efficacy and toxicity". In Bailey LB. Folate in Health and Disease (New York: Marcel Dekker). pp. 405–33. ISBN 0-8247-9280-7.
^ Morgan SL, Baggott JE, Alarcon GS (1997). "Methotrexate in rheumatoid arthritis: folate supplementation should always be given". BioDrugs 8 (1): 164–75. PMID 18020507. Click here to request reprint from publisher
^ Morgan SL, Baggott JE, Lee JY, Alarcon GS (1998). "Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low-dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention". Journal of Rheumatology 25 (3): 441–6. PMID 9517760.
^ Takimoto CH (1996). "New Antifolates: Pharmacology and Clinical Applications". Oncologist 1 (1 & 2): 68–81. PMID 10387971.
^ Gangjee A, Jain HD, Kurup S (September 2007). "Recent advances in classical and non-classical antifolates as antitumor and antiopportunistic infection agents: part I". Anticancer Agents Med Chem 7 (5): 524–42. PMID 17896913.

External links[edit]

Antifolates at the US National Library of Medicine Medical Subject Headings (MeSH)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 膀胱および泌尿器の転移性尿路上皮癌の治療 treatment of metastatic urothelial cancer of the bladder and urinary tract
2. 抗マラリア剤：概要 antimalarial drugs an overview
3. HIVとマラリア hiv and malaria
4. トリメトプリムスルファメトキサゾール：概要 trimethoprim sulfamethoxazole an overview
5. 鼻疽の治療および予後 treatment and prognosis of melioidosis

English Journal

Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study.

Warwick AB, Malempati S, Krailo M, Melemed A, Gorlick R, Ames MM, Safgren SL, Adamson PC, Blaney SM.SourceUniformed Services University of the Health Sciences, Bethesda, Maryland. anne.warwick@usuhs.edu.
Pediatric blood & cancer.Pediatr Blood Cancer.2013 Feb;60(2):237-41. doi: 10.1002/pbc.24244. Epub 2012 Jun 28.
BACKGROUND: Pemetrexed is a multi-targeted antifolate that inhibits key enzymes involved in nucleotide biosynthesis. We performed a phase 2 trial of pemetrexed in children with refractory or recurrent solid tumors, including CNS tumors, to estimate the response rate and further define its toxicity p
PMID 22745043

Long term persistence of clonal malaria parasite Plasmodium falciparum lineages in the Colombian Pacific region.

Echeverry DF, Nair S, Osorio L, Menon S, Murillo C, Anderson TJ.AbstractABSTRACT: BACKGROUND: Resistance to chloroquine and antifolate drugs has evolved independently in South America, suggesting that genotype - phenotype studies aimed at understanding the genetic basis of resistance to these and other drugs should be conducted in this continent. This research was conducted to better understand the population structure of Colombian Plasmodium falciparum in preparation for such studies.
BMC genetics.BMC Genet.2013 Jan 7;14(1):2. [Epub ahead of print]
ABSTRACT: BACKGROUND: Resistance to chloroquine and antifolate drugs has evolved independently in South America, suggesting that genotype - phenotype studies aimed at understanding the genetic basis of resistance to these and other drugs should be conducted in this continent. This research was condu
PMID 23294725

Japanese Journal

crizotinib耐性後に4次治療のpemetrexedが多発肝転移に著効したEML4-ALK陽性の肺腺癌の1例

森雅秀,玄山宗到,各務慎一,松浦邦臣,山口俊彦,横田総一郎
肺癌 52(2), 242-247, 2012
背景．echinoderm microtubule-associated protein-like 4（EML4)-anaplastic lymphoma kinase（ALK）肺癌に対し，ALK阻害剤であるcrizotinibが有用である．一方，葉酸代謝拮抗剤であるpemetrexed（PEM）は，肺腺癌に対し1次だけでなく2次以降の治療にも広く用いられている．症例．39歳女性，非喫煙者．右肺下 …
NAID 130002060241

Ｐｅｍｅｔｒｅｘｅｄによる薬剤性間質性肺炎が考えられた１例

藤田雄,平野聡,竹田雄一郎,杉山温人,小林信之,工藤宏一郎
肺癌 51(4), 237-242, 2011
背景．Pemetrexedは悪性胸膜中皮腫および進行期非小細胞肺癌を適応疾患とした複数の葉酸代謝酵素を同時に阻害する抗癌剤である．近年，特に肺癌領域においてその重要性が増している．一般に薬剤副作用が少ないと言われているが，現在までにpemetrexedによる薬剤性間質性肺炎の報告がいくつかなされている．症例．症例は76歳女性．労作時呼吸困難を主訴に当院入院となり，胸部X線にて右大量胸水を認めた．精 …
NAID 130000954001

メトトレキサートの体内動態に及ぼす非ステロイド性抗炎症薬の影響：　メタ・アナリシスによる検討

上井優一,鈴木里彩,岩本喜久生
YAKUGAKU ZASSHI 131(5), 853-861, 2011
… In conclusion, the integration of the published reports by these meta-analyses shows that NSAIDs increase blood levels of methotrexate by influencing renal excretion of the antifolate. …
NAID 130000678868